Previous Close | 0.3200 |
Open | 0.3200 |
Bid | 0.3150 x 0 |
Ask | 0.3200 x 0 |
Day's Range | 0.3125 - 0.3200 |
52 Week Range | 0.2300 - 0.4500 |
Volume | |
Avg. Volume | 51,477 |
Market Cap | 43.286M |
Beta (5Y Monthly) | 0.32 |
PE Ratio (TTM) | 10.50 |
EPS (TTM) | 0.0300 |
Earnings Date | Aug 08, 2024 - Aug 12, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | Sept 02, 1999 |
1y Target Est | N/A |
Driven by Fingerstick Blood and Room-Temperature Stable for POCTsMISSISSAUGA, Canada, July 25, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it is presenting results of a novel Quality Assessment Product (“QAP™”) for supporting Point-of-Care-Tests (“POCTs”) for infection with the Hepatitis C Virus (“HCV”) at the American Diagnostic and Laboratory Medicine (“ADLM”) conference taking plac
Announces its hosting of Associate Minister of Small Business of Ontario, the Honourable Nina Tangri, ...
Adds Product Development & QC Labs, Fully-Automated IVD Vial-Filling CapabilityMISSISSAUGA, Ontario, June 17, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces its hosting of Associate Minister of Small Business of Ontario, the Honourable Nina Tangri, to celebrate the opening of two expansions to its medical devices manufacturing capacity at one of its three adjacent Mississauga sites. Expansion